Inmed Pharma Company Spotlight
Company Spotlight

Inmed Pharmaceuticals

Description: InMed Pharma (CSE: IN, OTCQB: IMLFF) is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.

Inmed Pharma WebsiteInmed Pharma LinkedInInmed Pharma Email

Recent News

March 13, 2017
InMed Appoints Dr. Eric Hsu as Vice President, Preclinical Research and Development

March 12, 2018
InMed to Present at 30th Annual ROTH Capital Conference

March 6, 2018
InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research

Learn More

Want to learn more about InMed Pharmaceuticals?




Note: page will reload once form is submitted.

Get in touch

#340-200 Granville Street
Vancouver, BC
Canada V6C 1S4

Phone: (604) 669-7207
(604) 683-2506
Email: [email protected]

Mornings are better with Visual Capitalist.coffee_email1

Thank you!
Given email address is already subscribed, thank you!
Please provide a valid email address.
Please complete the CAPTCHA.
Oops. Something went wrong. Please try again later.